Brief: Egetis Therapeutics Initiates Rolling NDA Submission To FDA For Emcitate

Egetis Therapeutics AB (publ)

19/12/2025 06:04

Dec 19 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

INITIATES ROLLING NDA SUBMISSION TO FDA FOR EMCITATE

PLANS NDA COMPLETION EARLY 2026, FDA APPROVAL Q3 2026

Source text: ID:nMFNb8lb1t

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))